• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于幽门螺杆菌清除特异性治疗的感染微环境响应纳米前药

Infected microenvironment responsive nanoprodrug for the specific therapeutics of Helicobacter pylori clearance.

作者信息

Zeng Zishan, Jiang Jingwen, Sun Yue, Li Wanzhen, Zheng Dong, Lin Huanxin, Zhao Chunshun

机构信息

School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, PR China.

School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, PR China.

出版信息

Biomaterials. 2025 Dec;323:123415. doi: 10.1016/j.biomaterials.2025.123415. Epub 2025 May 17.

DOI:10.1016/j.biomaterials.2025.123415
PMID:40411983
Abstract

Helicobacter pylori (H. pylori) is considered as the major pathogenic factor related to multiple digestive diseases. However, the efficacy of first-line treatment containing antibiotics gradually declined. It is urgent to develop treatment with antibiotic reduction/abandonment to combat H. pylori. Based on our previous discovery that Cu(DTC) exhibited stronger bactericidal effect than that of disulfiram or diethyldithiocarbamate (DTC), we constructed an antibiotic-free therapeutic strategy composed of DTC prodrug, Cu and shikonin (SK) to eliminate H. pylori. DTC was firstly modified with nitroaromatic moiety to acquire DTC prodrug (NTR-DTC), which was further encapsulated into Cu-SK@DOPA to construct nanoprodrug Cu-SK@NTR-DTC to achieve the triple masking of DTC, Cu and SK for the specificity therapeutics. Cu-SK@NTR-DTC could penetrate mucus layer and mainly detain in the bacteria infection area. In the presence of H. pylori, DTC was released from NTR-DTC to recover activity of copper chelation, and competitively bound Cu from Cu-SK to form Cu(DTC). The released SK possessed the bactericidal sensitization effect on Cu(DTC). The H. pylori-activable dissociation of Cu-SK@NTR-DTC, and the local release of Cu(DTC) and SK seriously destructed the bacterial membranes integrity and induce H. pylori death, which provided a feasible strategy to address the clinical limitations of H. pylori clearance.

摘要

幽门螺杆菌(H. pylori)被认为是与多种消化系统疾病相关的主要致病因素。然而,含抗生素的一线治疗效果逐渐下降。开发减少/摒弃抗生素的治疗方法来对抗幽门螺杆菌迫在眉睫。基于我们之前的发现,即Cu(DTC)比双硫仑或二乙基二硫代氨基甲酸盐(DTC)具有更强的杀菌作用,我们构建了一种由DTC前药、铜和紫草素(SK)组成的无抗生素治疗策略来消除幽门螺杆菌。首先用硝基芳基部分修饰DTC以获得DTC前药(NTR-DTC),然后将其进一步封装到Cu-SK@DOPA中构建纳米前药Cu-SK@NTR-DTC,以实现对DTC、铜和SK的三重掩蔽以进行特异性治疗。Cu-SK@NTR-DTC可以穿透黏液层并主要滞留在细菌感染区域。在幽门螺杆菌存在的情况下,DTC从NTR-DTC中释放出来以恢复铜螯合活性,并与Cu-SK中的铜竞争性结合形成Cu(DTC)。释放出的SK对Cu(DTC)具有杀菌致敏作用。Cu-SK@NTR-DTC的幽门螺杆菌激活解离以及Cu(DTC)和SK的局部释放严重破坏了细菌膜的完整性并导致幽门螺杆菌死亡,这为解决幽门螺杆菌清除的临床局限性提供了一种可行的策略。

相似文献

1
Infected microenvironment responsive nanoprodrug for the specific therapeutics of Helicobacter pylori clearance.用于幽门螺杆菌清除特异性治疗的感染微环境响应纳米前药
Biomaterials. 2025 Dec;323:123415. doi: 10.1016/j.biomaterials.2025.123415. Epub 2025 May 17.
2
ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.ROS 触发的循环扩增效应:一种用于肿瘤特异性治疗的前药激活纳米放大器。
Acta Biomater. 2022 Oct 15;152:367-379. doi: 10.1016/j.actbio.2022.08.072. Epub 2022 Sep 7.
3
A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging.一种成纤维细胞激活蛋白α激活的纳米递药系统,用于递送二乙基二硫代氨基甲酸盐和铜以进行肿瘤治疗和成像。
Acta Biomater. 2024 Oct 1;187:316-327. doi: 10.1016/j.actbio.2024.08.009. Epub 2024 Aug 14.
4
Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of .磁场延长纳米颗粒驻留时间以提高. 的根除效率。
ACS Appl Mater Interfaces. 2020 Dec 9;12(49):54316-54327. doi: 10.1021/acsami.0c13101. Epub 2020 Nov 25.
5
Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.活性氧物种激活自扩增前药纳米制剂用于肿瘤特异性 Cu 螯合物化疗和级联光动力治疗。
Biomaterials. 2022 May;284:121513. doi: 10.1016/j.biomaterials.2022.121513. Epub 2022 Apr 4.
6
Fucoidan-modified antibiotic-free nanovesicles: A multidimensional approach to eradicate intracellular and extracellular Helicobacter pylori and restore gastrointestinal homeostasis.岩藻依聚糖修饰的无抗生素纳米囊泡:根除细胞内和细胞外幽门螺杆菌并恢复胃肠道稳态的多维方法。
Int J Biol Macromol. 2025 May;307(Pt 2):141786. doi: 10.1016/j.ijbiomac.2025.141786. Epub 2025 Mar 7.
7
Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.应对幽门螺杆菌抗生素耐药性的合适一线治疗方案:亚洲视角
Molecules. 2015 Apr 8;20(4):6068-92. doi: 10.3390/molecules20046068.
8
Mucus and Biofilm Penetrating Nanoplatform as an Ultrasound-Induced Free Radical Initiator for Targeted Treatment of Helicobacter pylori Infection.黏液和生物膜穿透纳米平台作为超声诱导自由基引发剂用于靶向治疗幽门螺杆菌感染。
Adv Healthc Mater. 2024 Aug;13(20):e2400363. doi: 10.1002/adhm.202400363. Epub 2024 May 11.
9
Antimicrobial Peptide Hydrogel with pH-Responsive and Controllable Drug Release Properties for the Efficient Treatment of Infection.具有 pH 响应和可控药物释放性能的抗菌肽水凝胶,用于高效治疗感染。
ACS Appl Mater Interfaces. 2024 Oct 2;16(39):51981-51993. doi: 10.1021/acsami.4c09185. Epub 2024 Sep 18.
10
Combatting Helicobacter pylori: A Focus on Nanomaterials.对抗幽门螺杆菌:聚焦纳米材料
Helicobacter. 2024 Nov-Dec;29(6):e70004. doi: 10.1111/hel.70004.

引用本文的文献

1
Biomaterials mediated 3R (remove-remodel-repair) strategy: holistic management of Helicobacter pylori infection.生物材料介导的3R(去除-重塑-修复)策略:幽门螺杆菌感染的整体管理
J Nanobiotechnology. 2025 Jul 1;23(1):475. doi: 10.1186/s12951-025-03455-2.